Line 26: |
Line 26: |
| An 'in the field' diagnostic procedure is the '''latex agglutination test '''(LAT) (Rurangirwa et al 1987b). This test is based on a polysaccharide isolated from Mccp (Rurangirwa et al 1987a) which is used to sensitise latex beads. The sensitised latex beads are then used to detect serum antibodies from goats infected with CCPP (Rurangirwa et al 1987b). The specificity of LAT was assessed using WM25 monoclonal antibody which is specific for Mccp (Rurangirwa et al 1987c; Belton et al 1994) and reacts with the polysaccharide (Rurangirwa et al 1992). The specificity of LAT was further confirmed by evaluating specific growth inhibiting rabbit antisera to various mycoplasma isolates (Rurangirwa et al 1987c). The sensitised latex beads are stable at 4°C, room temperature and 37°C for over one year. Thus the long shelf-life of the beads at different temperatures makes it possible to prepare large amounts which can be stored until used. The latex agglutination test is an excellent procedure for the diagnosis of CCPP and can be run in two minutes on samples of whole blood or serum, requires no sophisticated equipment or storage facilities and is adaptable to any laboratory or field conditions - an example of a pen-side diagnostic test. The test is carried out by mixing a drop of the sensitised beads with a drop of blood or serum from the suspected animal on a glass slide for one minute and the results read visually and recorded as positive or negative. LAT combined with presenting clinical signs and necropsy indicating fibrinous pleuropneumonia is confirmatory of Mccp associated CCPP. | | An 'in the field' diagnostic procedure is the '''latex agglutination test '''(LAT) (Rurangirwa et al 1987b). This test is based on a polysaccharide isolated from Mccp (Rurangirwa et al 1987a) which is used to sensitise latex beads. The sensitised latex beads are then used to detect serum antibodies from goats infected with CCPP (Rurangirwa et al 1987b). The specificity of LAT was assessed using WM25 monoclonal antibody which is specific for Mccp (Rurangirwa et al 1987c; Belton et al 1994) and reacts with the polysaccharide (Rurangirwa et al 1992). The specificity of LAT was further confirmed by evaluating specific growth inhibiting rabbit antisera to various mycoplasma isolates (Rurangirwa et al 1987c). The sensitised latex beads are stable at 4°C, room temperature and 37°C for over one year. Thus the long shelf-life of the beads at different temperatures makes it possible to prepare large amounts which can be stored until used. The latex agglutination test is an excellent procedure for the diagnosis of CCPP and can be run in two minutes on samples of whole blood or serum, requires no sophisticated equipment or storage facilities and is adaptable to any laboratory or field conditions - an example of a pen-side diagnostic test. The test is carried out by mixing a drop of the sensitised beads with a drop of blood or serum from the suspected animal on a glass slide for one minute and the results read visually and recorded as positive or negative. LAT combined with presenting clinical signs and necropsy indicating fibrinous pleuropneumonia is confirmatory of Mccp associated CCPP. |
| <br> | | <br> |
− |
| |
| Definite diagnosis is made by the isolation of'' M. capricolum ''subsp. ''capripneumoniae'' from clinical samples, usually lung tissue and may be a long and difficult process. The success of isolation depends primarily on the attention that is given to sample collection. | | Definite diagnosis is made by the isolation of'' M. capricolum ''subsp. ''capripneumoniae'' from clinical samples, usually lung tissue and may be a long and difficult process. The success of isolation depends primarily on the attention that is given to sample collection. |
| <br> | | <br> |
− |
| |
| The growth inhibition (GI) test is the simplest and most specific, but the least sensitive of the tests available. It depends on the direct inhibition of mycoplasma growth on solid media by specific hyperimmune serum, and detects primary surface antigens (Dighero et al., 1970). | | The growth inhibition (GI) test is the simplest and most specific, but the least sensitive of the tests available. It depends on the direct inhibition of mycoplasma growth on solid media by specific hyperimmune serum, and detects primary surface antigens (Dighero et al., 1970). |
| <br> | | <br> |
− | The direct and indirect fluorescent antibody tests are among the most effective, simple and rapid serological methods of identification for most mycoplasma (Rosendal and Black, 1972). Several forms have been described, the most commonly used one is the indirect fluorescent antibody (IFA) test which is applied to unfixed colonies on agar. | + | The direct and indirect [[Immunofluorescence|fluorescent antibody tests]] are among the most effective, simple and rapid serological methods of identification for most mycoplasma (Rosendal and Black, 1972). Several forms have been described, the most commonly used one is the indirect fluorescent antibody (IFA) test which is applied to unfixed colonies on agar. |
| <br> | | <br> |
− | The complement fixation test (CFT) and the indirect haemagglutination test (IHA) are serological methods of diagnosis, as is the ELISA. these have varying degrees of efficacy. | + | The complement fixation test (CFT) and the indirect haemagglutination test (IHA) are serological methods of diagnosis, as is the [[ELISA testing|ELISA]]. These have varying degrees of efficacy. |
− | <br>
| |
− | Until recently, isolation was the only way to confirm the presence of CCPP. Diagnostic systems based on PCR have been developed for the rapid detection, identification and differentiation of members of the M. mycoides cluster and the specific identification of M. capricolum subsp. capripneumoniae (Bashiruddin et al., 1994; Hotzel et al., 1996).
| |
− | The diagnosis of outbreaks of CCPP is complicated by other infectious agents causing similar syndromes. Pleuropneumonic disease resembling Mccp-associated CCPP can also be produced by Mycoplasma mycoides subsp. capri (Mmc) and caprine variants of M. mycoides subsp. mycoides (Mmm). Mmc was originally considered to be the cause of CCPP, but its full importance as a pathogen of goats has now become doubtful, both because of the discovery of the Mccp and because many isolates previously classified as Mmc have subsequently been found to be caprine variants of Mmm. Mmc has been isolated from several countries in Africa and Asia, and from Australia. The disease reproduced experimentally with Mmc is largely restricted to the thoracic cavity, with or without a septicaemic phase and death. In contrast, caprine variants of Mmm generally causes a syndrome which may include not only pleuropneumonia but also mastitis, polyarthritis, keratoconjunctivitis, acute septicaemic death, sometimes with symptoms of the central nervous system, and abortion. Mmm is a major cause of disease in goats in USA, France, Israel and India. Experimentally, the disease caused by Mccp differs from that produced by Mmc and Mmm in: being readily contagious and fatal to susceptible goats; not affecting sheep or cattle; not producing local oedematous reactions when injected subcutaneously; and being characterised histo-pathologically by an interstitial, intralobular oedema of the lung, compared with the thickening of the interlobular septa which is seen with Mmc and Mmm (Kaliner and MacOwan 1976). Pasteurella haemolytica (both biotypes A and T) and P. multocida have also been associated with pleuropneumonia in goats, although experimental evidence of their pathogenicity in this host is meagre.
| |
− | | |
| <br> | | <br> |
| + | Until recently, isolation was the only way to confirm the presence of CCPP. Diagnostic systems based on PCR have been developed for the rapid detection, identification and differentiation of members of the ''M. mycoides'' cluster and the specific identification of ''M. capricolum'' subsp. ''capripneumoniae'' (Bashiruddin et al., 1994; Hotzel et al., 1996). |
| + | |
| + | The diagnosis of outbreaks of CCPP is complicated by other infectious agents causing similar syndromes. Pleuropneumonic disease resembling Mccp-associated CCPP can also be produced by ''Mycoplasma mycoides'' subsp. ''capri'' (Mmc) and caprine variants of ''M. mycoides ''subsp.'' mycoides'' (Mmm). Mmc was originally considered to be the cause of CCPP, but its full importance as a pathogen of goats has now become doubtful, both because of the discovery of the Mccp and because many isolates previously classified as Mmc have subsequently been found to be caprine variants of Mmm. Mmc has been isolated from several countries in Africa and Asia, and from Australia. The disease reproduced experimentally with Mmc is largely restricted to the thoracic cavity, with or without a septicaemic phase and death. In contrast, caprine variants of Mmm generally causes a syndrome which may include not only pleuropneumonia but also mastitis, polyarthritis, keratoconjunctivitis, acute septicaemic death, sometimes with symptoms of the central nervous system, and abortion. Mmm is a major cause of disease in goats in USA, France, Israel and India. Experimentally, the disease caused by Mccp differs from that produced by Mmc and Mmm in: being readily contagious and fatal to susceptible goats; not affecting sheep or cattle; not producing local oedematous reactions when injected subcutaneously; and being characterised histo-pathologically by an interstitial, intralobular oedema of the lung, compared with the thickening of the interlobular septa which is seen with Mmc and Mmm (Kaliner and MacOwan 1976). Pasteurella haemolytica (both biotypes A and T) and P. multocida have also been associated with pleuropneumonia in goats, although experimental evidence of their pathogenicity in this host is meagre. |
| | | |
| == Treatment and Control == | | == Treatment and Control == |
− | The macrolides (erythromycin, spiramysin, and tylosin), tetracyclines and quinolones are active against M. capricolumsubsp. capripneumoniae. | + | The macrolides (erythromycin, spiramysin, and tylosin), tetracyclines and quinolones are active against ''M. capricolum'' subsp.'' capripneumoniae''. |
| <br> | | <br> |
| Control measures include prevention of mixing and good hygiene. Movement restrictions and slaughtering infected animals are recommended for countries that are newly infected. | | Control measures include prevention of mixing and good hygiene. Movement restrictions and slaughtering infected animals are recommended for countries that are newly infected. |
− |
| |
− | <br>
| |
| | | |
| == References == | | == References == |
Line 56: |
Line 51: |
| <br> | | <br> |
| Dighero MW, Bradstreet PCM, Andrews BE, 1970. Dried paper discs for serological identification of human mycoplasmas. Journal of Applied Bacteriology, 33:750-757. | | Dighero MW, Bradstreet PCM, Andrews BE, 1970. Dried paper discs for serological identification of human mycoplasmas. Journal of Applied Bacteriology, 33:750-757. |
| + | <br> |
| + | Hotzel H, Sachse K, Pfützner H, 1996. A PCR scheme for differentiation of organisms belonging to the Mycoplasma mycoides cluster. Veterinary Microbiology, 49(1/2):31-43; 21 ref. |
| <br> | | <br> |
| Hutcheon D, 1889. Contagious pleuro-pneumonia in goats at Cape Colony, South Africa. Veterinary Journal, 29:399-404. | | Hutcheon D, 1889. Contagious pleuro-pneumonia in goats at Cape Colony, South Africa. Veterinary Journal, 29:399-404. |
Line 87: |
Line 84: |
| Wesonga HO, Litamoi JK, Kagumba M, Wakhusama E, 1993. Relationship between clinical signs and early lesions of contagious caprine pleuropneumonia caused by Mycoplasma strain F38. Small Ruminant Research, 10(1):45-54; 15 ref. | | Wesonga HO, Litamoi JK, Kagumba M, Wakhusama E, 1993. Relationship between clinical signs and early lesions of contagious caprine pleuropneumonia caused by Mycoplasma strain F38. Small Ruminant Research, 10(1):45-54; 15 ref. |
| | | |
− | <br>
| + | |
− | [[Category:To_Do_-_CABI review]] | + | [[Category:CABI Expert Review]] |
| + | [[Category:Respiratory Diseases - Goat]] |
| + | [[Category:Respiratory Bacterial Infections]] |